Not exact matches
Genetic
diseases like retinitis pigmentosa destroy the photosensitive
cells of the eye, the photoreceptors, but often leave intact the other
cells in the retina: the bipolar
cells that the photoreceptors normally talk to, and the
ganglion cells that are the retina's output to the brain.
The drops protected the animals» retinal
ganglion cells and optic nerves, both of which are generally damaged by the
disease.
Nighttime restlessness is common among people with Alzheimer's, but now, scientists may have figured out why: The
disease appears to degrade melanopsin retinal
ganglion cells.
For example, if it turned out that you were losing
ganglion cells that responded to motion early in the
disease, then you can imagine designing visual field tests that would detect motion in particular and tell us whether or not people were losing certain kinds of
ganglion cells long before pressure increases or holes in their visual field would show up.
Current biomarkers that we have for glaucoma, intraocular pressure or visual field, are indirect measures at best; what's really causing the
disease is the loss of
ganglion cell function.
Current therapeutic strategies for glaucoma, the most common cause of irreversible blindness [1], act only to manage the condition and there are currently no means to replace the retinal
ganglion cells (RGCs) which are lost in this
disease.
But the «off» retinal
ganglion cell dendrites retracted very early in the
disease.
For example, if you were testing a drug, or even monitoring the progression of the
disease so that you could very finely tune the treatment to each individual patient, and so frequently and so quickly that you could prevent the loss of individual
ganglion cells, you ultimately would be preserving vision.
So, intraocular pressure may be elevated, axon transport fails, the axon ends up being physically damaged; the retinal
ganglion cells die relatively late in the
disease.
Of course, the retinal
ganglion cells and their axons are what degenerate in this
disease.
Why that's important is that we showed that there are many changes in that retinal
ganglion cell that are akin to what you see in other neurodegenerative
diseases.
As a group, the Catalyst For a Cure research team was able to show that the primary
cell that's affected in glaucoma, the retinal
ganglion cell, does not die early in the stages of the
disease.
What's important is that the CFC has shown that there are many changes in the retinal
ganglion cell akin to what is seen in other neurodegenerative
diseases such as Alzheimer's.
Neuroblastoma is a
disease in which malignant (cancer)
cells form in primitive nerve tissue called «
ganglions» or in
cells in the adrenal glands.
Leber Hereditary Optic Neuropathy (LHON) is a rare maternally inherited mitochondrial genetic
disease, characterized by the degeneration of retinal
ganglion cells that results in brutal and irreversible vision loss that can lead to legal blindness, and mainly affects adolescents and young adults.
The authors examine
diseases associated with
ganglion cells and discuss ideas for replacing or regenerating these
cells.
CFC research findings have shown that there are many changes in the retinal
ganglion cell akin to what is seen in other neurodegenerative
diseases such as Alzheimer's.
These range from visual stimulation experiments that allow us to tap into the specific sets of retinal
ganglion cells that are most vulnerable early in the
disease, to the evolution of new imaging techniques, largely thanks to Alf Dubra and Vivek Srinivasan's work in those areas, and the ability to image retinal
ganglion cells and their component parts like their axons which degenerate very early in glaucoma.
Martin Raff, MD: Glaucoma, in the end, is a
disease of the retinal
ganglion cells - the
cells in the eye that send their nerve process to the brain, carrying information about vision.
So for the last 15 years I've been studying retinal
ganglion cell biology trying to understand why they fail to survive after injury or in degenerative
diseases like glaucoma and also when their connections to the brain are interrupted why do they fail to regenerate to regrow, why do they fail to repair themselves, it's this fundamental problem that leads to permanent vision loss in glaucoma.
What we've discovered is that those
cells become active very early in the
disease, they become active even before we can detect that the neuron is sick, even before the
ganglion cell shows signs of degenerating, we find the glial
cells are becoming very, very active and that was a surprise and we published those findings.
The team identified a period of vulnerability for retinal
ganglion cells early in the
disease, when these
cells are more sensitive to metabolic insults and stressors.
Summary: Poor regeneration and reconnection of retinal
ganglion cell (RGC) axons is a major obstacle for treating ocular trauma and
diseases including glaucoma.
I think before they did that it was largely a mystery when and where
ganglion cells dying during the progression of this
disease.
Some eye
diseases, including glaucoma, damage the retinal
ganglion cells (RGCs) that make up the optic nerve.
The team will continue to develop and test an imaging - based biomarker that can be used in a clinical setting to enable us to understand the molecular changes to the
ganglion cells, so we can detect the
disease very early on.
Doctors determined that it was the result of Hirschsprung's
disease, a congenital disorder that occurs when the inside of the large intestine lacks certain nerve
cells, called
ganglion, that help stool move along to the bowel.
A core pillar of research on the pathogenesis of eye
diseases, like cataracts, glaucoma, and macular degeneration, has been on the role of mitochondrial dysfunction and death of retinal
ganglion cells (RGCs).